Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HUT vs GSK✓SelectedUSD · GSKHUT vs GSK performance historyLatest closeAs of-17.65%11/20
Stock and ETF performance explorer

HUT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+155.5%
GSK return
+88.3%
Excess return
+67.2%
Maximum drawdown
-95.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-17.7%-0.1%-17.5%-17.6%
7D-20.2%-5.3%-14.9%-19.4%
30D-35.8%-3.7%-32.1%-35.6%
3M-48.2%-7.3%-40.9%-47.7%
6M-52.4%-4.2%-48.1%-52.7%
YTD0.0%+0.9%-0.8%-2.4%
1Y+36.1%+7.3%+28.8%+30.1%
3Y+364.1%+52.7%+311.4%+259.6%
5Y-30.5%+40.1%-70.6%-44.1%
All+155.5%+88.3%+67.2%+74.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling